Complexity and challenges in defining myeloid-derived suppressor cells.

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Myeloid-derived suppressor cells (MDSCs) exhibit suppressive activity, negatively regulating the host immune response.
• MDSC expansion is observed in various cancers in mice and humans, correlating with disease progression and reduced survival.
• Monitoring MDSC expansion is clinically significant for cancer management.

Purpose of the Study:

• To review the identification and phenotyping of myeloid-derived suppressor cells (MDSCs).
• To discuss challenges in characterizing circulating and tumor-associated MDSCs in human and murine models.
• To highlight the importance of multicolor flow cytometry for accurate MDSC subset analysis.

Main Methods:

• Review of existing literature on MDSC identification and characterization.
• Discussion of flow cytometry techniques for MDSC phenotyping.
• Analysis of factors influencing MDSC expansion and differentiation.

Main Results:

• MDSCs are a heterogeneous population of immature myeloid cells from monocytic and granulocytic lineages.
• Tumor-derived soluble factors drive MDSC expansion and inhibit their differentiation.
• Accurate phenotyping necessitates multicolor approaches to capture MDSC heterogeneity.

Conclusions:

• Effective identification and phenotyping of MDSCs are critical for understanding their role in cancer.
• Multicolor flow cytometry is essential for comprehensive analysis of MDSC subsets.
• Addressing challenges in MDSC characterization will advance cancer immunotherapy research.